GNCA Genocea Biosciences Inc.

0.55
+0.01  (+2%)
Previous Close 0.53
Open 0.55
Price To Book 7.81
Market Cap 47375746
Shares 86,625,975
Volume 264,628
Short Ratio
Av. Daily Volume 296,926

Drug Information

Drug catalyst information is displayed when you hover over the stage bar graph.

Announced September 25, 2017 that development will be ceased.
GEN-003
Genital herpes
Topline data did not meet endpoints - September 2015
GEN-004
Universal vaccine candidate against pneumococcus
Phase 1/2 initial immunogenicity data due mid-2019.
GEN-009 vaccine
Various cancers

SEC Filings

  1. SC 13D/A [Amend] - General statement of acquisition of beneficial ownership 19625263
  2. SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals 19607736
  3. SC 13D/A [Amend] - General statement of acquisition of beneficial ownership 19600555
  4. 8-K - Current report 19587772
  5. 8-K - Current report 19512524
  6. 8-K - Current report 181232257
  7. 10-Q - Quarterly report [Sections 13 or 15(d)] 181154233
  8. 8-K - Current report 181152078
  9. 8-K - Current report 181102357
  10. 8-K - Current report 181083559